(Q43912882)

English

Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Tamoxifen plus chemotherapy versus tamoxifen alone as adjuvant therapies for node-positive postmenopausal women with early breast cancer: a stochastic economic evaluation (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Jonathan Karnon

1

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Jackie Brown

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Adjuvant Breast Cancer (ABC) Steering Committee

3

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

PharmacoEconomics

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

20

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

119-137

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

https://scigraph.springernature.com/pub.10.2165/00019053-200220020-00005

0 references

The clinical course of bone metastases from breast cancer

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220020-00005

21 January 2018

ABC of breast diseases. Metastatic breast cancer

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220020-00005

21 January 2018

Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer. International Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220020-00005

21 January 2018

Health and economic outcomes modeling practices: a suggested framework

1 reference

https://api.crossref.org/works/10.2165%2F00019053-200220020-00005

21 January 2018

Postmenopausal patients with node-positive resectable breast cancer. Tamoxifen vs FEC 50 (6 cycles) vs FEC 50 (6 cycles) plus tamoxifen vs control--preliminary results of a 4-arm randomised trial. The French Adjuvant Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human breast cancer: survival from first metastasis. Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant tamoxifen versus placebo in elderly women with node-positive breast cancer: long-term follow-up and causes of death

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inpatient costs of specific cerebrovascular events at five academic medical centers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals for cost/effectiveness ratios

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Probabilistic sensitivity analysis incorporating the bootstrap: an example comparing treatments for the eradication of Helicobacter pylori

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Key issues in the treatment of advanced breast cancer. Expectations and outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relapse of breast cancer after adjuvant treatment in premenopausal and perimenopausal women: patterns and prognoses

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of locoregional recurrent breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cost of breast cancer recurrences

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Summary measures and statistics for comparison of quality of life in a clinical trial of cancer therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy. The International Breast Cancer Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment costs of adjuvant cytotoxic therapy in premenopausal breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant chemoradiotherapy for patients with nonmetastatic breast carcinoma: side effects, quality of life, and organization.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recurrent breast cancer: presentation, diagnosis, and treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessing quality in decision analytic cost-effectiveness models. A suggested framework and example of application

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Breast cancer: a guide for fellows

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the Nationa

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Confidence intervals or surfaces? Uncertainty on the cost-effectiveness plane

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant CMFVP versus tamoxifen versus concurrent CMFVP and tamoxifen for postmenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Handling uncertainty in cost-effectiveness models

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Possible deleterious effect of tamoxifen in premenopausal women with locoregional recurrence of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pattern of metastases in human breast cancer. Influence of systemic adjuvant therapy and impact on survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Economic evaluation of the use of nadroparin calcium in the prophylaxis of deep vein thrombosis and pulmonary embolism in surgical patients in Italy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sensitivity analysis and the expected value of perfect information

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local-regional breast cancer recurrence following mastectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The costs of treating febrile neutropenia in six U.K. Hospitals

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatic arterial infusion chemotherapy for liver metastases from breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The significance of local recurrence of carcinoma of the breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Irradiation of bone metastases in breast cancer patients: a randomized study with 1 year follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The results of radiation therapy for isolated local regional recurrence after mastectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy with a doxorubicin regimen and long-term tamoxifen in premenopausal breast cancer patients: an Eastern Cooperative Oncology Group trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estimating uncertainty ranges for costs by the bootstrap procedure combined with probabilistic sensitivity analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of a breast cancer screening programme on quality-adjusted life-years

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The costs of treating breast cancer in the United Kingdom: implications for screening

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The International (Ludwig) Breast Cancer Study Group Trials I-IV: 15 years follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analysis of failures following local treatment of isolated local-regional recurrence of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How to compare quality of life of breast cancer patients in clinical trials. International Breast Cancer Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Bayesian approach to stochastic cost-effectiveness analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systematic overview of cost-utility assessments in oncology

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Should tamoxifen be a primary treatment choice for elderly breast cancer patients with locoregional disease?

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/11888364

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00019053-200220020-00005

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43912882&oldid=2104354167"